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Diet greatly influences gene expression and physi-
ology. In mammals, elucidating the effects and
mechanisms of individual nutrients is challenging
due to the complexity of both the animal and its
diet. Here, we used an interspecies systems biology
approach with Caenorhabditis elegans and two of its
bacterial diets, Escherichia coli and Comamonas
aquatica, to identify metabolites that affect the
animal’s gene expression and physiology. We iden-
tify vitamin B12 as the major dilutable metabolite
provided by Comamonas aq. that regulates gene
expression, accelerates development, and reduces
fertility but does not affect lifespan. We find that
vitamin B12 has a dual role in the animal: it affects
development and fertility via the methionine/S-
Adenosylmethionine (SAM) cycle and breaks down
the short-chain fatty acid propionic acid, preventing
its toxic buildup. Our interspecies systems biology
approach provides a paradigm for understanding
complex interactions between diet and physiology.
INTRODUCTION
Our diet provides building blocks for development and repro-
duction, aswell as energy to sustain daily cellular and organismal
activities. Complex diets consist of macronutrients such as car-
bohydrates, fats, and proteins but also provide micronutrients
such as vitamins that function as cofactors in metabolic reac-
tions. In mammals, nutrients are provided not only by diet but
are also synthesized by the gut microbiota (Hooper et al.,
2002). Amajor challenge is to unravel the contributions of individ-
ual metabolites to cellular and organismal physiology and to
dissect the metabolic and genetic underpinnings of physiolog-
ical responses to changing diets.The nematode C. elegans is an emerging model to study the
effects of diet on life history traits such as developmental rate,
fertility, and aging (Coolon et al., 2009; Gracida and Eckmann,
2013; MacNeil et al., 2013). C. elegans is a relatively simple
model organism composed of fewer than 1,000 somatic cells.
It lives in temperate climates around the globe and subsists on
diets of various bacterial species growing on rotting vegetation.
These bacteria also inhabit theC. elegans intestine to serve as its
microbiota (Fe´lix and Duveau, 2012). In the laboratory,
C. elegans are grown monoxenically on E. coli OP50, but many
other bacterial strains and species have been fed to worms as
well (Avery and Shtonda, 2003; Coolon et al., 2009; MacNeil
et al., 2013; Soukas et al., 2009). Bacteria supply C. elegans
with metabolites that can greatly affect its life history traits. For
instance, bacterially derived nitric oxide and folate extend and
limit the lifespan of the animal, respectively (Gusarov et al.,
2013; Virk et al., 2012). The effects of these metabolites were
identified by a hypothesis-driven approach (nitric oxide) or
serendipitously by a mutation in the bacteria (folate). Because
both C. elegans and its bacterial diet are genetically tractable,
we reasoned that this predator-prey combination could be
used for the unbiased identification of nutrients that drive tran-
scriptional and physiological responses in the animal.
We previously found that, relative to E. coli OP50, a diet of
Comamonas DA1877 accelerates C. elegans development and
decreases fertility and lifespan (MacNeil et al., 2013). These
physiological effects are accompanied by dramatic changes in
gene expression (MacNeil et al., 2013). For instance, the acyl-
CoA dehydrogenase-encoding gene acdh-1 is repressed several
hundred fold on the Comamonas DA1877 diet relative to E. coli
OP50. We created transgenic animals harboring the acdh-1 pro-
moter driving expression of GFP to generate a transgenic ‘‘die-
tary sensor’’ strain with which the transcriptional response to
the Comamonas DA1877 diet can be readily monitored in living
animals (MacNeil et al., 2013). Remarkably, the effects of Coma-
monasDA1877 onC. elegans gene expression and development
persist even when these bacteria are mixed in small amounts
with the E. coli OP50 diet, indicating that Comamonas DA1877Cell 156, 759–770, February 13, 2014 ª2014 Elsevier Inc. 759
generates one or more dilutable compounds to whichC. elegans
responds. Using the dietary sensor strain, we identified a
C. elegans network consisting of metabolic and regulatory
genes that, when perturbed, interferes with the transcriptional
response to Comamonas DA1877 (Watson et al., 2013).
Here, we used an interspecies systems biology approach to
identify bacterial metabolites that affectC. elegans gene expres-
sion and life history traits. We performed genetic screens in
E. coli and Comamonas to identify bacterial genes that, when
mutated, result in aberrant repression or activation of Pacdh-
1::GFP in C. elegans. We performed a secondary metabolite
screen by supplementing 25 candidate metabolites to Pacdh-
1::GFP animals. Eight compounds activated the dietary sensor,
including branched-chain amino acids, threonine, and propionic
acid. Two compounds repressed the sensor: methyl-cobalamin
(Me-Cbl) and adenosyl-cobalamin (Ado-Cbl), the two biologi-
cally active forms of vitamin B12. We demonstrate that vitamin
B12 is generated by Comamonas DA1877, but not by E. coli,
and that it drives many of the gene expression and physiological
changes inC. elegans induced by theComamonas diet. Interest-
ingly, all eight activating metabolites are closely connected in the
C. elegans metabolic network to the two enzymes that require
vitamin B12 as a cofactor. We find that vitamin B12 fulfills two
important physiological roles in C. elegans: it regulates develop-
ment through the synthesis of the major methyl donor SAM and
alleviates toxic buildup of the short-chain fatty acid propionic
acid. Our interspecies systems biology approach provides a
powerful paradigm for gaining insight into the complex interac-
tions between diet, metabolic regulation, and physiology.
RESULTS
Genetic Screens in Bacterial Diets
We previously determined that Comamonas DA1877 bacteria
must produce a dilutable compound to which C. elegans re-
sponds with altered gene expression programs, accelerated
development, and reduced fertility (MacNeil et al., 2013). We
reasoned that we could discover bacterial metabolites that affect
C. elegans by identifying bacterial genes involved in the genera-
tion, processing, or transport of these small molecules. We used
the C. elegans Pacdh-1::GFP dietary sensor as a reporter for
diet-induced gene expression changes—GFP expression is
high when the animals are fed E. coli OP50 but is barely detect-
able when the animals are fed Comamonas DA1877. We per-
formed genetic screens in each of these bacteria to identify
mutant strains that, when fed to C. elegans, alter GFP
expression.
First, we fed dietary sensor animals the Keio E. coli BW25113
collection, which contains deletion mutants for 3,985 of the
4,290 protein-coding genes (Baba et al., 2006). We visually
examined whether GFP expression was decreased or increased
relative to animals fed the wild-type strain (Figure 1A). In total, 70
mutant E. coli strains decreased GFP expression, and seven
caused an increase compared to the parent strain (Table S1
available online). Second, we performed a transposon-based
mutagenesis screenofComamonasDA1877bacteria (Figure1B).
Using a nonreplicating transposon, we generated 5,760 Coma-
monasDA1877mutants, each with a single transposon insertion.760 Cell 156, 759–770, February 13, 2014 ª2014 Elsevier Inc.Five mutant Comamonas DA1877 strains failed to repress GFP
expression when fed to the sensor strain (Table S2).
To facilitate the mapping of transposon insertions and identifi-
cation of the disrupted genes, we sequenced the Comamonas
DA1877 genome and annotated protein-coding sequences and
RNA genes (Figure S1A). Because there was no systematic
report on the taxonomic identity of Comamonas DA1877 before
this study, we first used the single 16S rRNA gene to identify this
strain at the species level as Comamonas aquatica, and we will
henceforth refer to Comamonas DA1877 as Comamonas aq.
DA1877.
We reasoned that bacterial mutants identified affect
C. elegans gene expression due to either the buildup or reduc-
tion in particular metabolites. A total of 77 E. coli and 5 Coma-
monas aq. DA1877 genes (Tables S1 and S2) were identified in
the bacterial screens. We focused on bacterial genes encoding
metabolic enzymes, transporters, and transcription factors
known to regulate metabolic operons. Mapping these genes
onto bacterial metabolic networks revealed that perturbation
of several different pathways affected GFP expression in
C. elegans (Figure 1C). For instance, mutations in enzymes
from E. coli purine metabolism, propionic acid metabolism, the
tricarboxylic acid (TCA) cycle, and the biosynthesis of sidero-
phores (iron scavengers) decreased dietary sensor activity.
Conversely, E. coli and Comamonas mutations in branched
chain amino acid biosynthesis and vitamin B12 biosynthesis/
import resulted in increased C. elegans dietary sensor activity.
AMetabolite Screen inC. elegans Identifies Vitamin B12
as the Candidate Dilutable Comamonas Molecule
We selected a subset of metabolites implicated by the bacterial
screens for use in a secondary screen in which their effect on
theC. elegans dietary sensor was tested by direct supplementa-
tion to either diet. We focused on 18 metabolites implicated
by bacterial genes encoding metabolic enzymes, transporters,
and transcription factors known to regulate metabolic operons.
We included seven additional metabolites that were implicated
from our earlier C. elegans genetic screens (Table S3) (Watson
et al., 2013). We supplemented the metabolites at various con-
centrations to thePacdh-1::GFP sensor strain fed either bacterial
diet (Figure 2A). Six metabolites caused mild, dose-dependent
increases in GFP expression when supplemented to the Coma-
monas aq. DA1877 diet, including the amino acids valine, isoleu-
cine, threonine, and glycine, aswell as homocysteine and vitamin
B6. Two metabolites, a-ketobutyrate and propionic acid, more
dramatically increased GFP expression when supplemented to
Comamonas aq.DA1877 and also further increasedGFP expres-
sion on the E. coli OP50 diet (Figure 2B).
Only two metabolites mimicked the strong repressive effect of
theComamonas aq. diet on the Pacdh-1::GFP sensor when sup-
plemented to E. coli OP50: the two biologically active forms of
vitamin B12, Ado-Cbl and Me-Cbl (Figure 2C). Vitamin B12 is an
attractive candidate to be the dilutable molecule produced by
Comamonas aq. DA1877 (MacNeil et al., 2013) for several rea-
sons. First, two of five Comamonas aq. DA1877 genes identified
in the transposon screen encode vitamin B12 biosynthetic en-
zymes (cbiA andcbiB, TableS2andFigureS1B). Second, vitamin
B12 was also implicated by the E. coli deletion collection screen,
Figure 1. Bacterial Screens
(A) Diagram of the Keio E. coli deletion collection screen.
(B) Diagram of Comamonas DA1877 transposon mutagenesis screen.
(C) Network of metabolites implicated by bacterial screens. SAICAR, 5-amino-4-imidazole-N-succinocarboxamide ribonucleotide; [acp], acyl carrier protein.
See also Figure S1 and Tables S1 and S2.even thoughE. colidonot synthesize this cofactor (seebelow). An
E. coli strain with a deletion in tonB, which encodes a protein
required for vitamin B12 import (Bassford et al., 1976; Kadner,1990), resulted in even greater levels of GFP expression when
fed to the sensor strain (Figure S1C). Third, Ado- and Me-Cbl
were the only repressors identified in the chemical screen, andCell 156, 759–770, February 13, 2014 ª2014 Elsevier Inc. 761
Figure 2. Metabolite Screen
(A) Summary of the observed effects of supple-
menting metabolites to Pacdh-1::GFP animals
fed either Comamonas aq. DA1877 (left column)
or E. coli OP50 (right column). Shades of green
represent relative GFP expression. Numbers indi-
cate metabolite concentrations (in mM).
(B) Pacdh-1::GFP animals fed Comamonas aq.
DA1877 bacteria alone or supplemented with the
indicated compounds that activate GFP expres-
sion. Exposure time is indicated in yellow. Exposure
time for inset images is 400 ms.
(C) Pacdh-1::GFP animals fed E. coliOP50 bacteria
supplemented with the indicated compounds that
repress GFP expression. Exposure time is indi-
cated in yellow. Exposure time for inset images is
400 ms.
See also Table S3.both robustly repress Pacdh-1::GFP in low (nM) doses. This fits
with the observation that mixing small amounts of the Comamo-
nas aq.DA1877 diet into the E. coliOP50 diet is sufficient to exert
gene expression and physiological changes (MacNeil et al.,
2013). Finally, mutations in the two C. elegans enzymes that use
vitamin B12 interfere with the transcriptional response to the
Comamonas aq. DA1877 diet (Watson et al., 2013). Vitamin B12
is an essential nutrient for most animals but is only synthesized
by some species of bacteria (Bender, 2003). It is used as a
cofactor by the same two enzymes in all vitamin B12-depen-
dent animals—methylmalonyl-CoA mutase (MUT; MMCM-1 in
C. elegans), which is involved in propionyl-CoA breakdown,
and methionine synthase (MS; METR-1 in C. elegans), which
is involved in the methionine/SAM cycle. Methylmalonyl-
CoA mutase uses Ado-Cbl, whereas methionine synthase
uses Me-Cbl (Figure S1D). We previously found that both of
these vitamin-B12-dependent enzymes, as well as others in762 Cell 156, 759–770, February 13, 2014 ª2014 Elsevier Inc.their respective pathways, are required
for Comamonas aq. DA1877-induced
gene expression changes (Watson et al.,
2013). Taken together, these results sug-
gest that vitamin B12 may be the dilutable
molecule provided by the Comamonas
aq. DA1877 diet that represses Pacdh-
1::GFP.
Vitamin-B12-Producing Bacteria
Repress the Dietary Sensor
Our results predict that vitamin B12 levels
are higher in the Comamonas aq. DA1877
than in the E. coli OP50 diet. To directly
compare the amounts of vitamin B12, we
measured Ado-Cbl by mass spectrom-
etry. Ado-Cbl levels are much higher in
Comamonas aq. DA1877 than in E. coli
OP50 (Figure 3A) but are reduced to
background in the Comamonas aq. cbiA
mutant, indicating that this mutant indeed
fails to synthesize vitamin B12.We fed additional bacterial species to Pacdh-1::GFP dietary
sensor animals and correlated their effect on GFP expression
with the presence or absence of a vitamin B12 biosynthesis
pathway. Four of these seven bacterial species have the capacity
to synthesize vitaminB12 (Karasseva et al., 1977; Lee et al., 2012),
and three do not (Figure 3B). We found that the presence or
absence of a vitamin B12 biosynthetic pathway in the genome of
the bacterial diet correlates perfectly with the repression or activa-
tion of the acdh-1promoter inC. elegans, respectively (Figure 3B).
Requirement of C. elegans Vitamin B12 Processing and
Utilization
Vitamin B12 repressed GFP expression equally well whether sup-
plemented to live or UV-killed E. coliOP50 diets, indicating that its
effects do not depend on E. colimodification or metabolism (Fig-
ure S2A). We wondered why Ado-Cbl and Me-Cbl repress the
dietary sensor equally well (Figure 2). From studies of human
Figure 3. Correlation between Vitamin B12 Biosynthesis and Repression of the Dietary Sensor
(A) Ado-Cbl contentmeasured bymass spectrometry in indicated bacterial strains. The red line indicates background levels of Ado-Cbl in thebacteria-free control.
Mean ± SEM is plotted from three replicate experiments.
(B) Correlation between vitamin B12 biosynthesis pathway presence and dietary sensor repression. Images ofPacdh-1::GFP animals fed various bacterial strains
are located below a cartoon that indicates pathway status. Differences in exposure times for the inset images are indicated in yellow.
See also Figure S2.cobalamin deficiency disorders, it is known that, after vitamin B12
is imported into the cell, it is stripped of its upper axial ligand, un-
dergoes several processing steps, is modified into Ado-Cbl and
Me-Cbl, and is distributed to the two enzymes that use it (Fig-ure S2B).Our supplementation experiments likely cannot discrim-
inate between individual effects of these two forms of vitamin
B12 because they can be interconverted. We wondered whether
vitamin B12 processing and/or distribution in C. elegans areCell 156, 759–770, February 13, 2014 ª2014 Elsevier Inc. 763
Figure 4. Chemical Epistasis with Vitamin
B12 and Propionic Acid on C. elegans
Gene Expression
(A) Network of the two vitamin-B12-dependent
pathways. Metabolites are indicated in rectangles.
Green metabolites activate the dietary sensor
when supplemented to the bacterial diet. Genes
encoding the metabolic enzymes involved are
indicatedwith arrowsbetweenmetabolites.Genes
that, whenmutated, activate the dietary sensor are
indicated in red. Red hexagons, vitaminB12; green
hexagons, vitamin B6; blue, folate metabolism.
5-Me-THF, 5-methyltetrahydrofolate; THF, tetra-
hydrofolate, the biologically active form of folate.
(B) Chemical epistasis of combined supplementa-
tionofAdo-Cbl andpropionicacidonPacdh-1::GFP
dietary sensor animals fed the E. coliOP50 diet.
(C) qRT-PCR of 14 Comamonas-upregulated
and 14 Comamonas-downregulated genes in
wild-type animals fed indicated diets and sup-
plemented metabolites. PA, propionic acid; N2,
wild-type animals. Changes in expression for each
gene are plotted as log2 fold change compared to
respective mRNA levels in wild-type animals fed
E. coli OP50 (first and third columns) or Coma-
monas aq. DA1877 (middle column).
See also Table S4.required for its repressive effect onPacdh-1::GFP. In our previous
C. elegans genetic screens, we did not retrieve any vitamin B12
import and processing genes (Watson et al., 2013), potentially
due to inherently high false-negative rates in RNAi screens
(Kamath et al., 2003). We predicted C. elegans vitamin B12 pro-
cessing genes based on homology with known human genes
(Figure S2B). RNAi of each of two genes tested, mtrr-1 and
Y76A2B.5, resulted in failure of both Me-Cbl and Ado-Cbl to
repress thedietary sensor (FigureS2C). This indicates that supple-
mented vitaminB12must beproperly processedand regenerated
into its active forms within C. elegans to repress Pacdh-1::GFP.
We previously found that enzymes in propionyl-CoA break-
down and the methionine/SAM cycle are required for the repres-
sive effect of the Comamonas aq. DA1877 diet on the dietary
sensor (Watson et al., 2013). Thus, one would predict that these
enzymes are also required for the repressive effects of vitamin
B12 supplementation. We used two deletion mutants in each of
thesepathways to testwhether theyarealso involved inmediating
the response to vitamin B12. Indeed, supplementation of vitamin
B12 to either propionyl-CoAbreakdownormethionine/SAMcycle
mutants failed to repress acdh-1 promoter activity (Figure S2D).764 Cell 156, 759–770, February 13, 2014 ª2014 Elsevier Inc.Taken together, vitamin B12 processing/
distributing genes and intact vitamin-
B12-dependent metabolic pathways are
required for the effect of this cofactor on
C. elegans.
Propionic Acid Can Override
Vitamin B12 to Activate the Sensor
Vitamin B12 represses the dietary
sensor, whereas vitamin B6, homocyste-ine, glycine, threonine, isoleucine, valine, a-ketobutyrate, and
propionic acid activate the acdh-1 promoter (Figure 2A). Inter-
estingly, the breakdown of each of these amino acids, as well
as a-ketobutyrate and propionic acid, involves conversion to
propionyl-CoA (Figure 4A). Vitamin B6 functions as a cofactor
in two reactions that lead to the production of propionyl-CoA
(Figure 4A). Because vitamin B12 increases flux through the
propionyl-CoA breakdown pathway, we hypothesized that the
balance between vitamin B12 and propionyl-CoA levels may
be the driving force controlling acdh-1 promoter activity. To
test this hypothesis, we performed a chemical epistasis experi-
ment and found that excess propionic acid can override the
repressive effects of vitamin B12 on the dietary sensor in a
dose-dependent manner (Figure 4B). This suggests that the
effects of vitamin B12 on the acdh-1 promoter may depend on
its capacity to repress the buildup of an activator, propionic acid.
Vitamin B12 Mimics Broad Comamonas aq.
DA1877-Mediated Gene Expression Changes
TheComamonas aq.DA1877 diet affects the expression ofmany
C. elegans genes, including acdh-1 (MacNeil et al., 2013). To
Figure 5. Effects of Metabolite Supplemen-
tation on C. elegans Development
(A) Developmental progression of synchronized
wild-type populations of animals fed indicated
diets and supplementedmetabolites. The parental
generation was cultivated on E. coli OP50.
(B) Developmental progression of synchronized
wild-type populations of animals fed indicated
diets and supplemented metabolites. PA, propi-
onic acid; vitamin B12, 64 nM Ado-Cbl. The
parental generationwas cultivated onE. coliOP50.
(C) Developmental progression of synchronized
wild-type and mutant populations of animals fed
indicated diets and supplemented metabolites.
64 nM of each variant of vitamin B12 was used.
(D) Developmental progression of synchronized
wild-type and mutant populations of animals fed
indicated diets and supplemented metabolites.
L-Met, 4 mM methionine. 56 mM folate was used.
See also Figure S3.assess whether vitamin B12 can elicit similar broad effects on
gene expression, we used quantitative RT-PCR (qRT-PCR) to
determine relative expression levels of 14 representative Coma-
monas-downregulated genes and 14 representative Comamo-
nas-upregulated genes in wild-type animals fed E. coliOP50 with
or without three doses of supplemented Me-Cbl or Ado-Cbl. All
but one of the genes tested changed in expression on the Coma-
monas aq. DA1877 diet, as described previously (MacNeil et al.,
2013). Most of the Comamonas-downregulated genes were also
downregulatedwhenanimalswere fedE.coliOP50supplemented
with either form of vitamin B12 (Figure 4C). Likewise, mostComa-
monas-upregulated genes were also activated by supplementa-
tionof vitaminB12 (Figure4C). Thus, vitaminB12supplementation
to the E. coli OP50 diet induces similar gene expression changes
as those elicited by the Comamonas aq. DA1877 diet.
Six vitamin B12-downregulated genes, including acdh-1, were
upregulated in response to propionic acid (Figure 4C). Further,Cell 156, 759–770,propionic acid could override the repres-
sive effect of vitamin B12 on these genes.
Interestingly, a subset of the vitamin-B12-
downregulated genes did not respond
to propionic acid. A similar trend was
observed among the vitamin-B12-acti-
vated genes; whereas some responded
to propionic acid, others did not. There-
fore, we determined that there are at least
two classes of vitamin-B12-responsive
genes: those that respond to propionic
acid (hereafter referred to as type 1) and
those that do not (type 2).
Vitamin B12 AcceleratesC. elegans
Developmental Rate and Egg
Laying Timing and Requires the
Methionine/SAM Cycle
Because vitamin B12 mimics the effects
of the Comamonas aq. DA1877 diet onC. elegans gene expression, we next tested whether it also
mimics the accelerated development, reduced fertility, and
accelerated aging induced by this bacterial diet (MacNeil et al.,
2013). Vitamin B12 supplementation affected neither the mean
nor the maximum lifespan of C. elegans (Figure S3A). This indi-
cates that another factor must be responsible for the Comamo-
nas aq. DA1877 effect on aging, which is in agreement with the
observation that a diet consisting of E. coli OP50 supplemented
with a small amount of Comamonas aq. DA1877 does not
shorten lifespan (MacNeil et al., 2013).
Addition of vitamin B12 to the E. coli OP50 diet did accelerate
development, although it did not fully recapitulate the extent of
developmental rate increase elicited by the Comamonas diet
(Figure 5A). This indicates that additional growth-enhancing bac-
terial factors may be provided by Comamonas. Propionic acid
supplementation to the E. coli OP50 diet slowed C. elegans
development, and supplementation of both propionic acid andFebruary 13, 2014 ª2014 Elsevier Inc. 765
vitamin B12 resulted in intermediate growth rates (Figure 5B).
Based on this observation, we hypothesized that propionic
acid levels may dictate developmental rate: low concentrations
caused by high vitamin B12 would accelerate development,
whereas high propionic acid levels that occur when vitamin
B12 is limiting would slow development. To test this hypothesis,
we measured developmental timing in four metabolic gene
mutants, two from each vitamin-B12-dependent pathway:
Dmce-1 and Dpcca-1 from propionyl-CoA metabolism and
Dmetr-1 and Dsams-1 from the methionine/SAM cycle. When
fed E. coli OP50, all four mutants exhibited slow growth
compared to wild-type animals (Figure 5C). Surprisingly, supple-
mentation of vitamin B12 accelerated development in Dmce-1
and Dpcca-1 mutant animals but failed to increase develop-
mental rate in Dmetr-1 and Dsams-1 mutants (Figure 5C).
Thus, vitamin-B12-induced developmental acceleration requires
a functional methionine/SAM cycle, but not the propionyl-CoA
breakdown pathway. Dmce-1 and Dpcca-1 mutants fail to
catabolize propionyl-CoA (Chandler et al., 2006), likely resulting
in a buildup of propionic acid. Neither Dmce-1 nor Dpcca-1mu-
tants can break down propionic acid even when vitamin B12 is
present, yet supplementation of this cofactor does accelerate
development in these mutants. These data suggest that the
levels of propionic acid are not the driving force behind develop-
mental rate but rather that development is accelerated via the
methionine/SAM cycle as a result of buildup or lack of specific
metabolites therein.
To further test this model, we first focused on metr-1 (methi-
onine synthase), which converts homocysteine to methionine
by using vitamin B12 as a cofactor. In this reaction, 5-methyl-
tetrahydrofolate is also converted to the biologically active
form of folate, tetrahydrofolate (Figure 4A). Loss of METR-1
function can be caused either by a mutation in the correspond-
ing gene or as a result of vitamin B12 deficiency. In humans,
loss of the corresponding enzyme leads to depletion of tetrahy-
drofolate and methionine and buildup of homocysteine. Folate
supplementation (which is converted to tetrahydrofolate in vivo)
did not rescue the slow growth of Dmetr-1 mutants (Figure 5D).
Thus, tetrahydrofolate depletion is not a primary cause
of developmental rate reduction. Methionine supplementation,
on the other hand, largely rescued the developmental rate
defect of Dmetr-1 mutants (Figure 5D). Interestingly, methionine
supplementation did not accelerate development of Dsams-1
mutant animals, which are impaired in converting methionine
to SAM (Figure 5D) (Walker et al., 2011). This suggests that
the developmental acceleration by methionine depends on its
conversion to SAM. Taken together, these data suggest that
vitamin B12 accelerates C. elegans development primarily
through its role as a cofactor in the methionine/SAM cycle,
rather than in propionyl-CoA breakdown. However, excess
propionic acid slows development, which is likely due to toxic
effects.
Supplementing E. coli with vitamin B12 reduced total brood
size and therefore mimics the Comamonas aq. DA1877 diet
with regard to this phenotype as well (Figure S3B). Both the Co-
mamonas aq.DA1877 diet and vitamin B12 supplemented E. coli
OP50 altered the dynamics of egg laying; animals laid almost all
of their eggs (93% and 96%, respectively) within the first 2 days.766 Cell 156, 759–770, February 13, 2014 ª2014 Elsevier Inc.In contrast, animals fed E. coli OP50 alone laid only 70% in the
first 2 days (Figure S3C). This vitamin-B12-induced shift to early
egg laying was still observed in Dpcca-1 mutants, but the effect
was lost inDmetr-1mutant animals (Figure S3B). Together, these
results indicate that vitamin B12 both accelerates development
and shifts egg-laying dynamics via its role in the methionine/
SAM cycle.
Vitamin B12 Protects against Propionic Acid Toxicity
and Requires the Propionyl-CoA Metabolism Pathway
The developmental acceleration induced by vitamin B12 did not
rely on its role in propionyl-CoA breakdown; however, vitamin
B12 did prevent some of the developmental deceleration
induced by high doses of propionic acid (Figure 5B). At such
high doses, propionic acid is toxic to the animal (Figures 2A
and 6A). We asked whether vitamin B12 supplementation could
alleviate the toxic effects of excess dietary propionic acid in wild-
type and Dpcca-1 mutant animals. Vitamin B12 increased toler-
ance to propionic acid in wild-type animals, but not in Dpcca-1
mutant animals, which are much more sensitive to propionic
acid supplementation in general (Figure 6A). This is in agreement
with the notion that animals lacking pcca-1 accumulate propi-
onic acid and cannot utilize vitamin B12 tometabolize it. Interest-
ingly, wild-type animals fed Comamonas aq. DA1877 are much
more resistant to propionic acid than those fed E. coli OP50
supplemented with 64 nM vitamin B12 (Figure 6A). This indicates
that Comamonas aq. DA1877 may provide additional com-
pounds that alleviate propionic acid toxicity or that these bacte-
ria metabolize more propionic acid, thus lowering the effective
concentration delivered to the animal.
We wondered whether loss of metr-1 would also increase
sensitivity to propionic acid toxicity. Surprisingly, Dmetr-1
mutants tolerated excess propionic acid slightly better than
wild-type animals, although this differencewas lost when vitamin
B12 was in ample supply (Figure 6B). When vitamin B12 is
limiting, it is conceivable that MMCM-1 and METR-1 compete
for this cofactor. As a result, MMCM-1 might be able to utilize
more of the vitamin B12 pool for the breakdown of propionic
acid when METR-1 is absent.
Transcription of acdh-1 is strongly activated in response
to propionic acid supplementation, vitamin-B12-deficient diets,
or mutations in any of the four enzymes required for vitamin
B12-dependent propionic acid breakdown. We wondered
what the physiological role of this activation could be and
reasoned that acdh-1 may function in response to propionic
acid buildup, perhaps to help dampen its toxic effects. We
tested the sensitivity of Dacdh-1 mutants to propionic acid
and found that they are much more sensitive than wild-type an-
imals (Figure 6B). Unlike Dpcca-1 mutants, however, Dacdh-1
mutants survived better on propionic acid when vitamin B12
was supplemented to the diet. This is likely because, unlike in
Dpcca-1 mutants, the vitamin-B12-dependent propionyl-CoA
breakdown pathway is still intact in Dacdh-1 mutant animals.
Taken together, type 1 vitamin B12 response genes that are
activated by propionic acid may help to rewire flux through
the metabolic network, thereby enabling the breakdown, excre-
tion, or conversion of this metabolite or alleviating its toxic
effects indirectly.
Figure 6. Effects of Vitamin B12 on Propi-
onic Acid Toxicity
(A) Toxicity analysis of incremental doses of pro-
pionic acid on wild-type and Dpcca-1 mutant
C. elegans in the absence and presence of 64 nM
Ado-Cbl (B12). Mean ± SEM is plotted from three
combined experiments.
(B) Percent survival of different C. elegans strains
fed E. coliOP50 at two concentrations of propionic
acid (PA) in the absence or presence of 64 nM
Ado-Cbl. Mean ± SEM is plotted from four com-
bined experiments.DISCUSSION
Using an interspecies systems biology approach withC. elegans
and two of its bacterial diets, we uncovered metabolites that
affect gene expression and life history traits. We identified
vitamin B12 as the major dilutable compound produced by
Comamonas aq. DA1877 that regulates gene expression, accel-
erates development, and affects fertility (MacNeil et al., 2013;
this study). Further, we determined that the balance between
vitamin B12 and propionyl-CoA is likely the main driving force
in the regulation of type 1 vitamin B12 response genes. This
finding may reconcile a puzzling observation, namely that both
vitamin B12 supplementation and starvation repress the dietary
sensor (MacNeil et al., 2013). How can supplementation of a
compound and the absence of a compound have the same
effect? In rats, starvation lowers levels of short-chain fatty acids,
including propionic acid, as animals catabolize their fat stores
(Illman et al., 1986). In worms, starvation and vitamin B12 supple-
mentation may have the same repressive effect on the dietary
sensor by reducing the levels of propionyl-CoA.
We identified different physiological functions for the two
vitamin-B12-dependent pathways in C. elegans: the methionine/
SAM cycle affects development and fertility, whereas the
propionyl-CoA breakdown pathway mitigates propionic acid-
induced toxicity (Figure 7). The observation that the methionine/
SAM cycle affects development is compatible with the notion
that this is an anabolic pathway that generates SAM, the major
methyl donor used to modify proteins such as histones (Liu et al.,
2013), and to synthesize phosphatidylcholine (Walker et al.,Cell 156, 759–770,2011), which is vital for the production of
cell membranes during development.
Vitamin B12 represses acdh-1 expres-
sion at the level of transcription, though
it is unclear whether it acts directly or indi-
rectly. We previously identified several
nuclear hormone receptors that control
the response of the acdh-1 promoter
to nutritional and metabolic conditions
(MacNeil et al., 2013; Watson et al.,
2013). Fat-soluble vitamins A and D are
direct ligands for nuclear hormone recep-
tors (Chawla et al., 2001). The C. elegans
genome encodes 274 nuclear hormone
receptors (Reece-Hoyes et al., 2005). Itis tempting to speculate that vitamin B12 directly interacts with
one or more of these nuclear hormone receptors. However, our
data indicate that vitamin B12 can only repress Pacdh-1 when
it can efficiently be used to break down propionyl-CoA because
metabolic perturbations that block propionyl-CoA breakdown or
supplementation of excess propionic acid to wild-type animals
can override the repressive effect of vitamin B12 on acdh-1
expression. We speculate that propionic acid may directly
interact with one or more nuclear hormone receptors to regulate
type 1 vitamin B12 response genes.
C. elegans is likely to encounter many different bacterial food
sources in the wild (Fe´lix and Duveau, 2012). Not all bacterial
species synthesize vitamin B12, and C. elegans may have
evolved an optimal gene expression program to help the animal
cope with diets low in vitamin-B12-producing bacteria. One
consequence of this gene expression program may be meta-
bolic rewiring; the expression levels of several metabolic genes
predicted to function in vitamin-B12-dependent pathways are
sensitive to dietary vitamin B12 content (MacNeil et al., 2013;
Watson et al., 2013). Turning various enzymes on or off at the
level of gene expression may help to optimize metabolic flux.
acdh-1 expression is induced dramatically when vitamin B12
levels are low and propionic acid levels are high. Although the
exact metabolic functions of the ACDH-1 enzyme are unknown,
we suspect that it may serve to reroute flux around propionyl-
CoA within the metabolic network when vitamin B12 is limited
to prevent toxic buildup of propionic acid in the animal. This
notion is supported by our observation that Dacdh-1 mutants
are sensitive to propionic acid toxicity.February 13, 2014 ª2014 Elsevier Inc. 767
Figure 7. Model
Our findings demonstrate that the Comamonas aq. DA1877 diet provides high
levels of vitamin B12, whereas the E. coli OP50 diet is low in this cofactor.
Vitamin B12 acts through two different pathways—it lowers levels of pro-
pionyl-CoA, thereby preventing propionic acid toxicity, and enables the syn-
thesis of methionine and SAM, thereby accelerating development and
reducing fertility. Methionine synthesis reduces levels of homocysteine and
likely propionyl-CoA levels. Our data suggest that vitamin B12 may affect
these processes by regulating the expression of different sets of genes (type 1
and type 2), some that respond oppositely to propionyl-CoA and others that
are insensitive to this metabolite.Our findings suggest that C. elegans development, as it has
been studied in the laboratory for decades using E. coli OP50,
which is low in vitamin B12, only reflects one natural state. It
will be interesting to study other characteristics of the animal
such as behavior, mating, and movement under ample vitamin
B12 conditions.
Vitamin B12 deficiencies in humans can have severe impacts
on health, causing anemias and neuropathies, as well as low
birth weight, developmental retardation, and defects in cognitive
abilities in children of vitamin-B12-deficient mothers (Pepper
and Black, 2011). Such deficiencies can lead to propionic and
methylmalonic acidemias, homocystinuria, methionine/SAM
deficiency, or a combination thereof, and it is not yet fully under-
stood which of these metabolic imbalances lead to physiolog-
ical and pathological consequences in humans. Each of these
different diseases can also be caused by inborn errors in meta-
bolic genes; for instance, propionic acidemia is caused by muta-
tions in the human ortholog of pcca-1 (Al-Lahham et al., 2010).
Altogether, the interspecies paradigm we present provides a
model to further characterize vitamin-B12-dependent processes
and may provide a platform for the development of dietary or
drug treatments for vitamin-B12-related deficiencies.
Vitamin B12 is an essential cofactor in mammals and
C. elegans (Bito et al., 2013) but is not used at all by plants, yeast,
and many insect species. The uneven distribution of vitamin B12
use among eukaryotes is interesting, as is the uneven distribution
of vitamin B12 biosynthetic capability among bacterial species.
Considering thatmany species of enteric bacteria can synthesize
this essential vitamin suggests that the chemical outsourcing of
vitamin B12 productionmay be an important keystone of amutu-
ally beneficial relationship between gut microbiota and host cells
(Albert et al., 1980; Goodman et al., 2009; LeBlanc et al., 2013).768 Cell 156, 759–770, February 13, 2014 ª2014 Elsevier Inc.The microbiota greatly affects its host’s metabolism (Tremaroli
and Ba¨ckhed, 2012). For instance, bacteria in the gut break
down dietary fiber, which results in the production of short-chain
fatty acids such as propionic acid that are absorbed by intestinal
epithelia and are used to generate energy (Al-Lahham et al.,
2010). Altogether, themicrobiota facilitate digestion, affect xeno-
biotic response to drugs and other chemicals (Haiser et al., 2013;
Maurice et al., 2013), and are critically important in the immuno-
logical defense (Kamada et al., 2013). The fact that both
C. elegans and its bacterial diets are genetically tractable pro-
vides a powerful system to further unravel the complex inter-
actions between diet, microbiota, metabolism, physiology and
pathology, and the molecular mechanisms involved.
EXPERIMENTAL PROCEDURES
C. elegans Strains
N2 (Bristol) was used as the wild-type strain, and animals were maintained
as described at 20C (Brenner, 1974). sams-1(ok2946), mce-1(ok243), pcca-
1(ok2282), metr-1(ok521), and acdh-1(ok1489) strains were provided by the
C. elegans Gene Knockout Consortium and were backcrossed as described
(Watson et al., 2013). We previously described the Pacdh-1::GFP strain
(VL749) (MacNeil et al., 2013).
Bacterial Strains
E. coli OP50, Serratia marcescens IGX2, and Comamonas aq. DA1877 were
obtained from the CGC. Pseudomonas aeruginosa PA14 (gacA mutant) was
a gift from Victor Ambros (UMMS), and Corynebacterium glutamicum
ATCC13032 and Comamonas testosteroni ATCC11996 were obtained from
ATCC. Mycobacterium smegmatis MC2-155 was a gift from Chris Sassetti
(UMMS). For the killed bacteria experiment, E. coli OP50 and Comamonas
aq. DA1877 cultures were grown to log phase in LB, harvested and washed,
irradiated with UV (254nm, 5 J/cm2), concentrated, and added to NGM plates.
E. coli Deletion Collection Screen
Keio E. coli deletion collection clones (Thermo Scientific) were grown overnight
in Luria Broth (LB) containing 50 mg/ml kanamyacin in 96-well deepwell dishes.
15 ml of this overnight culture was seeded onto 96-well nematode growth
media (NGM) agar plates containing 50 mg/ml kanamyacin. Pacdh-1::GFP
gravid adults fed the Keio parent strain were bleached to harvest embryos,
which were subsequently washed in M9 media and allowed to hatch overnight
to synchronize the population by L1 arrest. Approximately 25 synchronized L1
animals were added to each well of the seeded plates. After incubating 48 hr at
20C, animals were visually screened for GFP expression. Each plate from the
Keio collection was screened twice; thus, each E. coli gene was screened four
times. Deletion mutants that affected GFP expression in at least two out of four
experiments were considered hits.
Comamonas aq. DA1877 Transposon-Based Mutagenesis Screen
See Supplemental Information.
Comamonas aq. DA1877 Genome Sequencing, Assembly, and
Annotation
See Supplemental Information.
Vitamin B12 Biosynthesis Pathway Analysis
To determine the presence or absence of vitamin B12 biosynthesis pathway in
bacterial species used in this study, we first gathered EC numbers from KEGG
(Kanehisa et al., 2012) and MetaCyc (Caspi et al., 2010) for all reactions
comprising this pathway. For Comamonas aq. DA1877, we cross-referenced
these EC numbers against all EC numbers annotated in the draft metabolic
network reconstruction from SEED and determined which vitamin B12 biosyn-
thesis enzymes were encoded in the genome. For other bacterial species, we
determined the presence or absence of vitamin B12 biosynthesis genes based
on the same EC numbers but used KEGG and Metacyc databases to guide
annotation. If an EC number in the vitamin B12 biosynthesis pathway was an-
notated as present for a particular species in either or both of these databases,
we called it present.
Metabolite Screen
Metabolites were purchased from Sigma-Aldrich and dissolved in water to the
maximum soluble concentration. Dilutions were made in water as indicated in
Figure 2. For each stock solution, pH was adjusted to 6.0 with sodium hydrox-
ide or hydrochloric acid. Stock solutions were added to NGM in various doses






Embryos from N2 wild-type gravid adults grown on E. coli OP50 were har-
vested, washed, and hatched overnight in M9 to synchronize the population.
Synchronized L1s were added to plates containing various concentrations of
Me-Cbl or Ado-Cbl (both from Sigma) and/or propionic acid, seeded with
E. coli OP50 or Comamonas DA1877. Animals were harvested for each condi-
tion when the majority of the population reached young adult stage. Total RNA
was isolated using Trizol (Invitrogen) and then purified of contaminating DNA
by DNaseI treatment followed by cleanup using QIAGEN RNeasy columns.
cDNA was reverse transcribed from RNA using oligo(dT)12-18 primer and
Mu-MLV reverse transcriptase (NEB). Primer sequences for qRT-PCR were
generated using the GETprime database (Gubelmann et al., 2011) and are
listed in Table S4. qRT-PCR reactions were performed in triplicate using the
Applied Biosystems StepOnePlus Real-Time PCR system and Fast Sybr
Green Master Mix (Invitrogen). Relative transcript abundance was determined
using the DDCt method and was normalized to averaged ama-1 and act-1
mRNA levels (Livak and Schmittgen, 2001).
Developmental Rate, Fertility, and Lifespan Assays
For all experiments, animals were grown at 20C. We measured the develop-
mental state of a population by synchronizing animals by L1 arrest in M9 for
20 hr and then allowing animals to develop for 45 hr at 20C under various
dietary conditions. For L-methionine and folate supplementations, solutions
(5 mg/ml L-Met in water or 0.1 mg/ml folate in 20% ethanol) were added on
top of plain NGM plates and dried prior to bacterial seeding. After 45 hr,
35–80 animals were mounted on agarose pads and visually categorized on
a compound microscope into age groups based on the development of the
vulva and germline as described (MacNeil et al., 2013).
Brood sizes were determined by transferring 30 L4 animals onto individual
plates containing E. coli OP50, Comamonas aq. DA1877, or E. coli OP50 sup-
plemented with 64 nM Ado-Cbl. Animals were transferred to new individual
plates daily, and the number of viable offspring on the plates was counted after
hatching.
For the lifespan assays,125 L4 animals were transferred onto NGM plates
containing 0.1 mg/ml FUDR, with or without vitamin B12, and seeded with
either E. coli OP50 or Comamonas aq. DA187. Animals were checked for
body movement or pharyngeal pumping every 2 days. If no pumping was
observed, animals were lightly tapped with a sterile platinum wire, and if
animals failed to respond to the touch stimulus, they were considered dead.
Propionic Acid Toxicity Assay
Approximately 100 starved L1 animals were placed on NGM media with
increasing concentrations of propionic acid (pH 6.0). After 48 hr, live animals
were counted. Each dose of propionic acid was analyzed in triplicate.
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